Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
$1,000 bribes, Mormon momfluencer mixers and making content to get plastic surgery: The wildest things I learned reporting my book - 2IVE 2026 'Show What I Am' Tour: How to get tickets, prices, dates and more
- 3Renewables cover over 50% of German electricity consumption in Q1
- 4Solid Propensities: Little Changes for a Superior Life
- 5Trying to improve your health and wellness in 2026? Keep it simple
- Would you ever turn to AI for companionship? 6% of Americans say they could — or already have.
- Game theory explains why reasonable parents make vaccine choices that fuel outbreaks
- Clocks to go forward one hour in Europe as summer time starts
- Nitty gritty Manual for Picking Agreeable Tennis shoes
- Phenomenal Web-based MBA Stages for Proficient Headway
- Director Emerald Fennell explains why "Wuthering Heights" has quotation marks around the title
- 5 Great High-Mileage Electric Vehicles Of 2024
- 6 Travel Services for Colorful Get-aways: Pick Your Fantasy Escape
- New movies to watch this weekend: See 'The Running Man' in theaters, rent 'One Battle After Another,' stream 'Nobody 2' on Peacock
